CollabRx Chairman Marty Tenenbaum will chair a panel session entitled “Let’s Look at Cancer: What’s Happening in Personalized Medicine” at the 7th Annual Burrill & Company Personalized Medicine Meeting in October. View the Burrill Personalized Medicine Meeting Agenda.
Founder Marty Tenenbaum takes role of Chairman. About CollabRx…
CollabRx CEO Marty Tenenbaum and CTO Jeff Shrager describe Cancer Commons and propose curing cancer as a new Grand Challenge for AI in the latest issue of AI Magazine. Read Abstract or Download Complete PDF.
A Statement from Marty Tenenbaum The entire team of staff, board members and advisors at CollabRx is saddened by the unexpected passing of our friend and colleague, John G. Curd, MD. As our consulting Chief Medical Officer, Dr. Curd played an invaluable role in making CollabRx what it is today. Dr. Curd’s intelligence and professional […]
The American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization that leverages information technology to personalize cancer treatments and accelerate research have forged a strategic partnership to develop innovative, Web-based decision support tools that enable physicians and their patients to better […]
Three CollabRx Scientists/Execs To Speak at Silicom Ventures’ Personalized Medicine World Conference
CollabRx CEO Dr. Marty Tenenbaum, CTO Dr. Jeff Shrager, and CollabRx Editor in Chief Dr. George Lundberg will be speaking at the 2011 Silicom Ventures’ Personalized Medicine World Conference on January 18 and 19, 2011. See Full Speaker List
Marty Tenenbaum, CollabRx CEO, is interviewed in the online business journal Xconomy. Read the Article “Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons”.
CollabRx CTO Dr. Jeff Shrager and Director of Engineering Dr. Randy Gobbel collaborated with eight other researchers in publishing “Targeted Therapy Database (TTD): A Model to Match Patient’s Molecular Profile with Current Knowledge on Cancer Biology”, which appeared in the open source journal PLoS ONE. Read Targeted Therapy Database (TTD): A Model to Match Patient’s […]
Amos Barzilay discussed the current state of the fight against cancer as well as potential business opportunities in personalized medicine at the Silicom Summit on personalized medicine on August 11, 2009. View Event Details